ARTICLE | Company News
MorphoSys, University of Texas MD Anderson Cancer Center deal
May 30, 2016 7:00 AM UTC
MorphoSys and MD Anderson Cancer Center partnered to use MorphoSys’ Ylanthia technology to discover and develop antibodies against undisclosed targets selected by both parties to treat cancer. Both pa...